ADVFN - Advanced Financial Network.
HOME» NYSE » M » MDT Stock Price » MDT Stock News

Medtronic Share News

 Medtronic, Inc. Stock Price
MDT Stock Price
 Medtronic, Inc. Stock Chart
MDT Stock Chart
 Medtronic, Inc. Stock News
MDT Stock News
 Medtronic, Inc. Company Information
MDT Company Information
 Medtronic, Inc. Stock Trades
MDT Stock Trades

Medtronic Issues Battery Depletion Advisory For Heart Devices

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- A small percentage of Medtronic Inc.'s (MDT) heart devices may have problems where battery life depletes faster than expected, the company said in an online advisory earlier this week. Medtronic no longer sells the models in question. An estimated 39,000 EnTrust implantable defibrillators are implanted world-wide. Implantable defibrillators provide a shock to the heart when needed in patients with irregular heartbeat. The battery in the EnTrust devices is supposed to last at least three months after an elective replacement indicator comes on. Medtronic said that as of last month, there have been 60 confirmed events that involved a drop in battery voltage over a time period ranging from one week to six months. The company has identified the cause of the incidents to be a battery short that develops toward the end of the device's life. All reported events have occurred at least 30 months after implant. Medtronic shares were down 1% to $37.76 in recent trading. The stock is down 1.3% this year. No patient deaths or serious injuries have been reported. "Ongoing impact from the advisory appears limited," said Derrick Sung, an analyst at Bernstein, in a note Friday. He said the issue looks manageable. "Physicians need simply to replace the device as soon as the elective replacement indicator is reached." Medtronic isn't the only medical devices company that has dealt with battery problems in its heart rhythm devices. Competitor St. Jude Medical Inc. (STJ) faced similar concerns in a subset of its defibrillators late last year. The advisory comes as medical device makers face a challenging market for implantable defibrillators. Domestic sales have slumped on a Department of Justice investigation and a study published last year that indicated the devices were being used outside clinical guidelines. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Medtronic (MDT)
DateTimeHeadline
12/06/201606:00:42Medtronic's Endurant(TM) II/IIs Stent Graft System Receives CE...
12/05/201617:21:36Quarterly Report (10-q)
12/05/201606:25:26Statement of Changes in Beneficial Ownership (4)
12/02/201613:08:00Medtronic Files 8K - Changes Executive Management
12/02/201612:39:19Current Report Filing (8-k)
12/01/201609:30:36Medtronic Announces Reimbursement Approval and Launch of CoreValve(TM...
11/29/201610:00:22Medtronic Announces U.S. Launch of Integrated Health Solutions...
11/29/201609:00:16Medtronic First to Receive European Approval for Less-Invasive...
11/23/201612:33:46Statement of Changes in Beneficial Ownership (4)
11/22/201613:00:00Medtronic Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22/201611:31:00Medtronic Cuts Guidance on Sluggish Revenue -- Update
11/22/201609:44:00U.S. Hot Stocks: Hot Stocks to Watch
11/22/201608:40:00Medtronic Cuts Guidance on Sluggish Revenue
11/22/201608:31:00Medtronic Cuts Guidance on Sluggish Revenue
11/22/201606:48:59Current Report Filing (8-k)
11/22/201606:45:37Medtronic Reports Second Quarter Financial Results
11/17/201616:30:13New Data Show Medtronic Heli-FX EndoAnchor System Enhances Outcomes...
11/16/201610:00:32Medtronic Releases FY16 Integrated Performance Report
11/16/201607:01:41Medtronic's Solitaire(TM) Stent Retriever Device Receives Expanded...
11/15/201611:15:12Medtronic's Endurant(TM) II/IIs Stent Graft System Delivers Positive...

Medtronic and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US